|
1
|
Weinberg BA, Marshall JL and Salem ME: The
Growing Challenge of Young Adults With Colorectal Cancer. Oncology
(Williston Park). 31:381–389. 2017.PubMed/NCBI
|
|
2
|
Yiu AJ and Yiu CY: Biomarkers in
Colorectal Cancer. Anticancer Res. 36:1093–1102. 2016.PubMed/NCBI
|
|
3
|
Kuipers EJ, Grady WM, Lieberman D,
Seufferlein T, Sung JJ, Boelens PG, van de Velde CJ and Watanabe T:
Colorectal cancer. Nat Rev Dis Primers. 1:150652015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cai Y, Yu X, Hu S and Yu J: A brief review
on the mechanisms of miRNA regulation. Genomics Proteomics
Bioinformatics. 7:147–154. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mohr AM and Mott JL: Overview of microRNA
biology. Semin Liver Dis. 35:3–11. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fabian MR, Sonenberg N and Filipowicz W:
Regulation of mRNA translation and stability by microRNAs. Annu Rev
Biochem. 79:351–379. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Krol J, Loedige I and Filipowicz W: The
widespread regulation of microRNA biogenesis, function and decay.
Nat Rev Genet. 11:597–610. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kwak PB, Iwasaki S and Tomari Y: The
microRNA pathway and cancer. Cancer Sci. 101:2309–2315. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Farazi TA, Spitzer JI, Morozov P and
Tuschl T: miRNAs in human cancer. J Pathol. 223:102–115. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qu H, Xu W, Huang Y and Yang S:
Circulating miRNAs: Promising biomarkers of human cancer. Asian Pac
J Cancer Prev. 12:1117–1125. 2011.PubMed/NCBI
|
|
12
|
Gentilin E, Degli Uberti E and Zatelli MC:
Strategies to use microRNAs as therapeutic targets. Best Pract Res
Clin Endocrinol Metab. 30:629–639. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Iorio MV and Croce CM: MicroRNA
dysregulation in cancer: Diagnostics, monitoring and therapeutics.
A comprehensive review. EMBO Mol Med. 9:8522017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sur DG, Colceriu M, Sur G, Aldea C,
Silaghi C, Samasca G, Lupan I, Căinap C, Burz C and Irimie A:
MiRNAs roles in the diagnosis, prognosis and treatment of
colorectal cancer. Expert Rev Proteomics. 16:851–856. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wei L, Wang X, Lv L, Zheng Y, Zhang N and
Yang M: The emerging role of noncoding RNAs in colorectal cancer
chemoresistance. Cell Oncol (Dordr). 42:757–768. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wan TMH, Iyer DN and Ng L: Roles of
microRNAs as non-invasive biomarker and therapeutic target in
colorectal cancer. Histol Histopathol. 35:225–237. 2020.PubMed/NCBI
|
|
17
|
Wang YG, He Q, Guo SQ and Shi ZZ: Reduced
serum miR-98 predicts unfavorable clinical outcome of colorectal
cancer. Eur Rev Med Pharmacol Sci. 23:8345–8353. 2019.PubMed/NCBI
|
|
18
|
Zhang L, Li B, Zhang B, Zhang H and Suo J:
miR-361 enhances sensitivity to 5-fluorouracil by targeting the
FOXM1-ABCC5/10 signaling pathway in colorectal cancer. Oncol Lett.
18:4064–4073. 2019.PubMed/NCBI
|
|
19
|
Kleemann M, Schneider H, Unger K, Sander
P, Schneider EM, Fischer-Posovszky P, Handrick R and Otte K:
miR-744-5p inducing cell death by directly targeting HNRNPC and
NFIX in ovarian cancer cells. Sci Rep. 8:90202018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen S, Shi F, Zhang W, Zhou Y and Huang
J: miR-744-5p inhibits non-small cell lung cancer proliferation and
invasion by directly targeting PAX2. Technol Cancer Res Treat.
18:15330338198769132019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim K, Yoo D, Lee HS, Lee KJ, Park SB, Kim
C, Jo JH, Jung DE and Song SY: Identification of potential
biomarkers for diagnosis of pancreatic and biliary tract cancers by
sequencing of serum microRNAs. BMC Med Genomics. 12:622019.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dolat L, Hu Q and Spiliotis ET: Septin
functions in organ system physiology and pathology. Biol Chem.
395:123–141. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cerveira N, Correia C, Bizarro S, Pinto C,
Lisboa S, Mariz JM, Marques M and Teixeira MR: SEPT2 is a new
fusion partner of MLL in acute myeloid leukemia with
t(2;11)(q37;q23). Oncogene. 25:6147–6152. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Angelis D and Spiliotis ET: Septin
Mutations in Human Cancers. Front Cell Dev Biol. 4:1222016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu W, Ding X, Chen F, Liu M, Shen S, Gu X
and Yu L: The phosphorylation of SEPT2 on Ser218 by casein kinase 2
is important to hepatoma carcinoma cell proliferation. Mol Cell
Biochem. 325:61–67. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu D, Liu A, Wang X, Chen Y, Shen Y, Tan Z
and Qiu M: Repression of Septin9 and Septin2 suppresses tumor
growth of human glioblastoma cells. Cell Death Dis. 9:5142018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Neubauer K and Zieger B: The Mammalian
Septin Interactome. Front Cell Dev Biol. 5:32017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chandrashekar DS, Bashel B, Balasubramanya
SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and
Varambally S: UALCAN: A portal for facilitating tumor subgroup gene
expression and survival analyses. Neoplasia. 19:649–658. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yuan Q, Fan Y, Liu Z, Wang X, Jia M, Geng
Z, Zheng J and Lu X: miR-744-5p mediates lncRNA HOTTIP to regulate
the proliferation and apoptosis of papillary thyroid carcinoma
cells. Exp Cell Res. 392:1120242020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Azeem S, Gillani SW, Siddiqui A,
Jandrajupalli SB, Poh V and Syed Sulaiman SA: Diet and colorectal
cancer risk in Asia - a systematic review. Asian Pac J Cancer Prev.
16:5389–5396. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sui Y, Lin G, Zheng Y and Huang W: LncRNA
MAFG-AS1 boosts the proliferation of lung adenocarcinoma cells via
regulating miR-744-5p/MAFG axis. Eur J Pharmacol. 859:1724652019.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fung KY, Dai L and Trimble WS: Cell and
molecular biology of septins. Int Rev Cell Mol Biol. 310:289–339.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu M, Shen S, Chen F, Yu W and Yu L:
Linking the septin expression with carcinogenesis. Mol BiolRep.
37:3601–3608. 2010.
|
